As a service to the global R&D community, Science|Business has compiled this database of funding opportunities. Users are encouraged to let us know of funding calls that could be incorporated into the database. Please email all suggestions to [email protected]. The database will be updated daily. For rapid news about COVID-19, see our live blog.
Targeted on four priorities identified by the WHO : 1) epidemiological and translational studies; 2) the pathophysiology of the disease (not including vaccines); 3) infection prevention and control measures in the healthcare setting (including the
Amount
€3M
Agency or Funder
French Agence Nationale de la Recherche
Eligibility (if available)
Scientists from research institutes/organizations or company with French headquarters
Proposals should address COVID-19 infection in malignant and benign haematologic disorders or haematological and immunological manifestations in COVID-19 infection.
Applications must address clinical (hospital or outpatient) or community-related aspects of COVID-19. Translational projects will be preferred. Basic research at the cellular level, or into animals, will not be considered.
Amount
$25,000 USD
Agency or Funder
CHEST Foundation
Eligibility (if available)
Health professionals, clinical researchers and non-profts that are members of CHEST
Additional support for current Clinical and Translational Science Award (CTSA) award recipients for digital health platforms, planning of COVID-19 trials and clinical study data.
Amount
Not limited
Agency or Funder
National Center for Advancing Translational Sciences
Eligibility (if available)
Clinical and Translational Science Award (CTSA) award recipients